| pubmed-article:19168349 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19168349 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19168349 | lifeskim:mentions | umls-concept:C0221908 | lld:lifeskim |
| pubmed-article:19168349 | lifeskim:mentions | umls-concept:C0153467 | lld:lifeskim |
| pubmed-article:19168349 | lifeskim:mentions | umls-concept:C0205065 | lld:lifeskim |
| pubmed-article:19168349 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:19168349 | lifeskim:mentions | umls-concept:C0210657 | lld:lifeskim |
| pubmed-article:19168349 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:19168349 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:19168349 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:19168349 | pubmed:dateCreated | 2009-4-28 | lld:pubmed |
| pubmed-article:19168349 | pubmed:abstractText | We conducted a randomised phase II study to assess the safety and efficacy of standard versus high-dose pemetrexed in platinum-resistant epithelial ovarian cancer (PR-EOC). The expression of ten genes was also examined as potential biomarkers of pemetrexed/platinum activity. | lld:pubmed |
| pubmed-article:19168349 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19168349 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19168349 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19168349 | pubmed:month | May | lld:pubmed |
| pubmed-article:19168349 | pubmed:issn | 1879-0852 | lld:pubmed |
| pubmed-article:19168349 | pubmed:author | pubmed-author:VergoteIgnace... | lld:pubmed |
| pubmed-article:19168349 | pubmed:author | pubmed-author:SehouliJalidJ | lld:pubmed |
| pubmed-article:19168349 | pubmed:author | pubmed-author:CalvertHilary... | lld:pubmed |
| pubmed-article:19168349 | pubmed:author | pubmed-author:KaiserChristo... | lld:pubmed |
| pubmed-article:19168349 | pubmed:author | pubmed-author:ZimmermannAnn... | lld:pubmed |
| pubmed-article:19168349 | pubmed:author | pubmed-author:MayolKatiaK | lld:pubmed |
| pubmed-article:19168349 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19168349 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:19168349 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19168349 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19168349 | pubmed:pagination | 1415-23 | lld:pubmed |
| pubmed-article:19168349 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:meshHeading | pubmed-meshheading:19168349... | lld:pubmed |
| pubmed-article:19168349 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19168349 | pubmed:articleTitle | A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer. | lld:pubmed |
| pubmed-article:19168349 | pubmed:affiliation | University Hospital Leuven, Division of Gynaecological Oncology, Gasthuisberg, Herestraat 49, Leuven, BE-3000, Belgium. | lld:pubmed |
| pubmed-article:19168349 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19168349 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19168349 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19168349 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19168349 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19168349 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19168349 | lld:pubmed |
